A Multicentre, Observational, Prospective Study to Assess the Safety profile of Rituximab in combination with chemotherapy in Patients With B cell-lineage Chronic Lymphocytic Leukaemia (B-CLL).

Trial Profile

A Multicentre, Observational, Prospective Study to Assess the Safety profile of Rituximab in combination with chemotherapy in Patients With B cell-lineage Chronic Lymphocytic Leukaemia (B-CLL).

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Aug 2014

At a glance

  • Drugs Rituximab (Primary) ; Antineoplastics
  • Indications Chronic lymphocytic leukaemia
  • Focus Adverse reactions
  • Acronyms MABERYC
  • Sponsors Roche
  • Most Recent Events

    • 07 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 03 Feb 2014 Planned End Date changed from 1 Jan 2014 to 1 Feb 2014 as per ClinicalTrials.gov record.
    • 23 May 2013 Planned End Date changed from 1 Jun 2014 to 1 Jan 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top